<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sengupta D</submitter><funding>NCI NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>460-6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4622756</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(6)</volume><pubmed_abstract>Pathologic c-Myc expression is frequently detected in human cancers, including Merkel cell carcinoma (MCC), an aggressive skin cancer with no cure for metastatic disease. Bromodomain protein 4 (BRD4) regulates gene transcription by binding to acetylated histone H3 lysine 27 (H3K27Ac) on the chromatin. Super-enhancers of transcription are identified by enrichment of H3K27Ac. BET inhibitor JQ1 disrupts BRD4 association with super-enhancers, downregulates proto-oncogenes, such as c-Myc, and displays antitumor activity in preclinical animal models of human cancers. Here we show that an enhancer proximal to the c-Myc promoter is enriched in H3K27Ac and associated with high occupancy of BRD4, and coincides with a putative c-Myc super-enhancer in MCC cells. This observation is mirrored in tumors </pubmed_abstract><journal>Epigenetics</journal><pubmed_title>Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.</pubmed_title><pmcid>PMC4622756</pmcid><funding_grant_id>P30GM103450</funding_grant_id><funding_grant_id>R33CA173264</funding_grant_id><funding_grant_id>P30 GM103450</funding_grant_id><funding_grant_id>R01GM106024</funding_grant_id><funding_grant_id>P20GM103429</funding_grant_id><pubmed_authors>Vural E</pubmed_authors><pubmed_authors>Kannan A</pubmed_authors><pubmed_authors>Kern M</pubmed_authors><pubmed_authors>Moreno MA</pubmed_authors><pubmed_authors>Stack B</pubmed_authors><pubmed_authors>Gao L</pubmed_authors><pubmed_authors>Suen JY</pubmed_authors><pubmed_authors>Sengupta D</pubmed_authors><pubmed_authors>Tackett AJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.</name><description>Pathologic c-Myc expression is frequently detected in human cancers, including Merkel cell carcinoma (MCC), an aggressive skin cancer with no cure for metastatic disease. Bromodomain protein 4 (BRD4) regulates gene transcription by binding to acetylated histone H3 lysine 27 (H3K27Ac) on the chromatin. Super-enhancers of transcription are identified by enrichment of H3K27Ac. BET inhibitor JQ1 disrupts BRD4 association with super-enhancers, downregulates proto-oncogenes, such as c-Myc, and displays antitumor activity in preclinical animal models of human cancers. Here we show that an enhancer proximal to the c-Myc promoter is enriched in H3K27Ac and associated with high occupancy of BRD4, and coincides with a putative c-Myc super-enhancer in MCC cells. This observation is mirrored in tumors </description><dates><release>2015-01-01T00:00:00Z</release><publication>2015</publication><modification>2026-04-07T23:02:59.321Z</modification><creation>2019-03-27T02:00:52Z</creation></dates><accession>S-EPMC4622756</accession><cross_references><pubmed>25941994</pubmed><doi>10.1080/15592294.2015.1034416</doi></cross_references></HashMap>